AA
Abhinav Ashok Kumar Kansal
About Abhinav Ashok Kumar Kansal
Data last updated:
Abhinav Ashok Kumar Kansal is a Director at Hbc Lifesciences Private Limited (since 2009), Director at Hbc Healthcare Private Limited (since 2020) and Director at Hbcdermiza Healthcare Private Limited (since 2018), and holds 3 more current directorships. The companies operate in Pharma and Travel and Hospitality. The 4 current companies with reported revenue have a combined latest revenue of ₹188 Cr; the largest is Hbc Lifesciences Private Limited at ₹145 Cr (FY 2024). Earlier, Abhinav Ashok Kumar Kansal was a Director at Avensis Pharmaceuticals Private Limited (2014–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2009 | 2008 | ₹145 Cr (FY 2024) | Active | |
| Director | 10 Nov 2020 | 2020 | ₹27.06 Cr (FY 2024) | Active | |
| Director | 09 Jan 2018 | 2018 | ₹15.86 Cr (FY 2025) | Active | |
| Director | 02 Jan 2020 | 2016 | ₹7.3 Lakh (FY 2025) | Active | |
| Designated Partner | 24 Aug 2025 | 2025 | Active | ||
| Director | 31 Jan 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2014 | 2014 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Abhinav Ashok Kumar Kansal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhinav Ashok Kumar Kansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhinav Ashok Kumar Kansal
Abhinav Ashok Kumar Kansal currently holds 6 directorships: Hbc Lifesciences Private Limited (Director, since 01 Apr 2009, revenue ₹145 Cr (FY 2024)); Hbc Healthcare Private Limited (Director, since 10 Nov 2020, revenue ₹27.06 Cr (FY 2024)); Hbcdermiza Healthcare Private Limited (Director, since 09 Jan 2018, revenue ₹15.86 Cr (FY 2025)); Hbc Hotels Private Limited (Director, since 02 Jan 2020, revenue ₹7.3 Lakh (FY 2025)); Takshraj Buildcon Llp (Designated Partner, since 24 Aug 2025); and 1 more.
Abhinav Ashok Kumar Kansal was first appointed on 01 Apr 2009 as Director at Hbc Lifesciences Private Limited. The most recent appointment on record is 24 Aug 2025 at Takshraj Buildcon Llp.
The 4 current companies of Abhinav Ashok Kumar Kansal that report revenue have a combined latest revenue of ₹188 Cr: Hbc Lifesciences Private Limited ₹145 Cr (FY 2024); Hbc Healthcare Private Limited ₹27.06 Cr (FY 2024); Hbcdermiza Healthcare Private Limited ₹15.86 Cr (FY 2025); Hbc Hotels Private Limited ₹7.3 Lakh (FY 2025).
Abhinav Ashok Kumar Kansal held 1 earlier board appointment: Avensis Pharmaceuticals Private Limited (Director, 20 Mar 2014 to 26 Feb 2020).
The current boards of Abhinav Ashok Kumar Kansal's companies include Ankur Jayantibhai Parmar (Hbc Lifesciences Private Limited), Hasmukh Shankerbhai Patel (Hbc Lifesciences Private Limited), Himanshu Shankerlal Patel (Hbc Lifesciences Private Limited), Maheshkumar Amrutlal Galiya (Hbc Lifesciences Private Limited), Sanjay Surendrabhai Shah (Hbc Lifesciences Private Limited), Sunny Brijesh Merja (Hbc Lifesciences Private Limited), among others.